STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

NDAQ Rule 144 Notice: 2,105 Common Shares Proposed Sale on 09/02/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Nasdaq, Inc. (NDAQ) shows that a person identified in the filing is selling common stock under Rule 144. The broker listed is Morgan Stanley Smith Barney LLC and the proposed transaction date is 09/02/2025. The filing reports 2,105 shares to be sold with an aggregate market value of $196,228.10 against 573,795,242 shares outstanding, and discloses prior sales by the same person on 08/01/2025, 07/01/2025, and 06/06/2025 totaling roughly $567,549 in gross proceeds. The securities were acquired as performance shares on 02/22/2023 and 02/20/2024. The filer attests they are unaware of undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine Rule 144 insider sales disclosed; sizes are immaterial relative to total outstanding shares.

The filing documents a proposed sale of 2,105 common shares via Morgan Stanley Smith Barney with an aggregate market value of $196,228.10 and lists three recent monthly sales in June–August 2025. Compared with 573.8 million shares outstanding, the transactions represent an immaterial fraction of the float. The shares were granted as performance awards in 2023 and 2024, indicating these are disposition of vested compensation rather than open-market programmatic sales tied to corporate stress. For investors, the filing documents transparency required under Rule 144 but does not, on its face, indicate material change to company capital structure or operations.

TL;DR: Insider is selling vested performance shares under Rule 144; disclosure aligns with compliance expectations.

The notice includes required representations about lack of undisclosed material information and cites a broker and planned sale date. The acquisition dates and nature of the awards are provided, which supports traceability of the insider's holding period compliance. Repeated monthly sales are disclosed, but given the small absolute size versus outstanding shares, this appears to be routine liquidity by an individual beneficiary rather than a governance or control event. Documentation appears to meet standard Form 144 disclosure elements.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 for NDAQ disclose?

The filing discloses a proposed sale of 2,105 common shares with aggregate market value $196,228.10, broker Morgan Stanley Smith Barney LLC, and planned sale date 09/02/2025.

Who previously sold Nasdaq (NDAQ) shares for this account in the last three months?

The filing lists prior sales by Jeremy Skule on 08/01/2025 (2,105 shares, $201,006.45), 07/01/2025 (2,105 shares, $187,702.85), and 06/06/2025 (2,104 shares, $178,840.00).

How were the shares being sold acquired?

The shares were acquired as performance shares from the issuer on 02/22/2023 (1,755 shares) and 02/20/2024 (350 shares).

Does the filing indicate any undisclosed material information about Nasdaq (NDAQ)?

The filer represents by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.

What exchange and broker are involved in the proposed sale?

The proposed sale is to be effected on NASDAQ through Morgan Stanley Smith Barney LLC located at 1 New York Plaza, 8th Floor, New York, NY 10004.
Nasdaq Inc

NASDAQ:NDAQ

NDAQ Rankings

NDAQ Latest News

NDAQ Latest SEC Filings

NDAQ Stock Data

51.28B
451.02M
10.72%
85.64%
1.07%
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
Link
United States
NEW YORK